First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
15 09 2021
Historique:
pubmed: 16 9 2021
medline: 22 1 2022
entrez: 15 9 2021
Statut: epublish

Résumé

Nosocomial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks among health care workers have been scarcely reported so far. This report presents the results of an epidemiologic and molecular investigation of a SARS-CoV-2 outbreak among laundromat facility workers in a large tertiary centre in Israel. Following the first three reported cases of SARS-CoV-2 among laundromat workers, all 49 laundromat personnel were screened by qRT-PCR tests using naso- and oropharingeal swabs. Epidemiologic investigations included questionnaires, interviews and observations of the laundromat facility. Eleven viral RNA samples were then sequenced, and a phylogenetic analysis was performed using MEGAX.The integrated investigation defined three genetic clusters and helped identify the index cases and the assumed routes of transmission. It was then deduced that shared commute and public showers played a role in SARS-CoV-2 transmission in this outbreak, in addition to improper PPE use and social gatherings (such as social eating and drinking). In this study, we present an integrated epidemiologic and molecular investigation may help detect the routes of SARS-CoV-2 transmission, emphasising such routes that are less frequently discussed. Our work reinforces the notion that person-to-person transmission is more likely to cause infections than environmental contamination (e.g. from handling dirty laundry).

Identifiants

pubmed: 34521489
doi: 10.1017/S0950268821002016
pii: S0950268821002016
pmc: PMC8770847
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e18

Références

Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Clin Microbiol Infect. 2020 Dec;26(12):1658-1662
pubmed: 32919072
Lancet Respir Med. 2020 Jul;8(7):658-659
pubmed: 32473123
Clin Microbiol Infect. 2020 Nov;26(11):1560.e1-1560.e4
pubmed: 32717416
J Clin Epidemiol. 1990;43(1):87-91
pubmed: 2319285
J Hosp Infect. 2020 Dec;106(4):678-697
pubmed: 32956786
JAMA. 2020 Dec 1;324(21):2155-2156
pubmed: 33185657
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
BMJ. 2020 Apr 9;369:m1435
pubmed: 32273267
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Sci Rep. 2020 Jul 29;10(1):12732
pubmed: 32728118
BMC Public Health. 2006 Aug 14;6:207
pubmed: 16907978
Int J Environ Res Public Health. 2020 Jun 27;17(13):
pubmed: 32605056
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2005-2011
pubmed: 32638221
Int J Environ Res Public Health. 2020 Apr 23;17(8):
pubmed: 32340347
mSphere. 2020 Jul 1;5(4):
pubmed: 32611701
Lancet. 2020 Mar 21;395(10228):922
pubmed: 32199474
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
J R Soc Interface. 2012 May 7;9(70):938-48
pubmed: 21937487
Viruses. 2020 Aug 05;12(8):
pubmed: 32764372
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Clin Infect Dis. 2021 Jan 27;72(2):265-270
pubmed: 33501962
JAMA Netw Open. 2020 Mar 2;3(3):e204583
pubmed: 32227177
J Hosp Infect. 2016 Mar;92(3):235-50
pubmed: 26597631
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33277325

Auteurs

Miki Goldenfeld (M)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Neta Zuckerman (N)

Central Virology Laboratory, Ministry of Health, Tel Hashomer, Ramat Gan, Israel.

Sharon Amit (S)

Clinical Microbiology, Sheba Medical Center, Ramat Gan, Israel.

Ilana Tal (I)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.

Sabrina Hasson (S)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.

Shiraz Gefen-Halevi (S)

Clinical Microbiology, Sheba Medical Center, Ramat Gan, Israel.

Asaf Biber (A)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Orna Mor (O)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Central Virology Laboratory, Ministry of Health, Tel Hashomer, Ramat Gan, Israel.

Gili Regev-Yochay (G)

Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH